8 Best Small-Cap Growth Stocks to Buy According to Analysts

Page 7 of 7

1. Celldex Therapeutics, Inc. (NASDAQ:CLDX)

Market Capitalization: $1.91 Billion

Number of Hedge Fund Holders: 34

Analyst Upside Potential: 142.96%

Celldex Therapeutics, Inc. (NASDAQ:CLDX) is a biopharmaceutical company that specializes in developing new treatments for diseases related to mast cells, which are a type of immune cell involved in allergic reactions and other inflammatory responses. Some of its notable products include Barzolvolimab, which is being tested for Chronic Urticarias, Prurigo nodularis, and Eosinophilic Esophagitis.

It ranks as the best small-cap growth stock to buy according to analysts. The stock was held by 34 hedge funds in Q2 2024, as per Insider Monkey’s database. Analysts’ 12-month median price target indicates more than 142% upside from the current levels.

Celldex Therapeutics, Inc. (NASDAQ:CLDX) on September 25, presented significant findings from a 52-week Phase 2 study of Barzolvolimab, focusing on its effectiveness for patients with Chronic Spontaneous Urticaria (CSU). The results show that 71% of patients receiving Barzolvolimab at a dose of 150 mg every 4 weeks achieved a complete response by Week 52, meaning they experienced no hives or itchiness. The results indicated that Barzolvolimab sets a new standard for treating CSU, showing robust efficacy regardless of prior treatment experiences.

Moreover, during the second quarter of fiscal 2024, the company reported $2.5 million in revenue increasing from $0.3 million in the comparable quarter of 2023. The increase in revenue was attributed to an increase in services performed under its research and development agreement with Rockefeller University. The company had $802.3 million in cash and cash equivalents which the management thinks is enough to fund operations till 2027.

While we acknowledge the potential of Celldex Therapeutics, Inc. (NASDAQ:CLDX) to grow, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for a promising AI stock that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.

Disclosure. None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 7 of 7